LINC01909

Across TCGA pan-cancer cohorts, LINC01909 RNA is linked to patient survival in 29 of 34 cancer types, making it the most broadly survival-associated LINC01909 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC01909 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01909 expression acts as an unfavorable survival marker, although some lineages such as UCEC and LAML show a favorable association.

ACC, UVM, and LGG are the cancer types where LINC01909 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Median	III,IV	0.368	0.812	<.001	114	view →
UVM	OS	Quartile	III,IV	0.341	1.000	.003	80	view →
LGG	DFS	Median	All	0.655	0.814	<.001	46	view →
SKCM	OS	Tertile	All	0.844	0.922	.009	28	view →
UCS	DFS	Quartile	II,III,IV	0.183	0.704	.003	24	view →
UCEC	DFS	Tertile	All	0.683	0.519	.004	18	view →
KIRC	DFS	Median	IV	0.496	0.739	.015	18	view →
LAML	DFS	Median	All	0.577	0.256	.003	18	view →
BLCA	OS	Tertile	IV	0.256	0.684	.008	16	view →
ESCA	OS	Quartile	III,IV	0.697	0.284	.002	12	view →
LIHC	DFS	Quartile	III,IV	0.550	0.168	.011	11	view →
PCPG	OS	Median	All	1.000	0.726	.012	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 29 lineages.

LINC01909–ACC (OS)

Open the ACC breakdown →